Cargando…

P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY

Detalles Bibliográficos
Autores principales: Mizuhara, K., Kobayashi, T., Nakao, M., Takahashi, R., Kaneko, H., Shimura, K., Hirakawa, K., Uoshima, N., Kamitsuji, Y., Wada, K., Kawata, E., Isa, R., Fujino, T., Matsumura-Kimoto, Y., Tsukamoto, T., Mizutani, S., Shimura, Y., Taniwaki, M., Kuroda, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430938/
http://dx.doi.org/10.1097/01.HS9.0000847376.12611.2e
_version_ 1784779915178016768
author Mizuhara, K.
Kobayashi, T.
Nakao, M.
Takahashi, R.
Kaneko, H.
Shimura, K.
Hirakawa, K.
Uoshima, N.
Kamitsuji, Y.
Wada, K.
Kawata, E.
Isa, R.
Fujino, T.
Matsumura-Kimoto, Y.
Tsukamoto, T.
Mizutani, S.
Shimura, Y.
Taniwaki, M.
Kuroda, J.
author_facet Mizuhara, K.
Kobayashi, T.
Nakao, M.
Takahashi, R.
Kaneko, H.
Shimura, K.
Hirakawa, K.
Uoshima, N.
Kamitsuji, Y.
Wada, K.
Kawata, E.
Isa, R.
Fujino, T.
Matsumura-Kimoto, Y.
Tsukamoto, T.
Mizutani, S.
Shimura, Y.
Taniwaki, M.
Kuroda, J.
author_sort Mizuhara, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9430938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94309382022-08-31 P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY Mizuhara, K. Kobayashi, T. Nakao, M. Takahashi, R. Kaneko, H. Shimura, K. Hirakawa, K. Uoshima, N. Kamitsuji, Y. Wada, K. Kawata, E. Isa, R. Fujino, T. Matsumura-Kimoto, Y. Tsukamoto, T. Mizutani, S. Shimura, Y. Taniwaki, M. Kuroda, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430938/ http://dx.doi.org/10.1097/01.HS9.0000847376.12611.2e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Mizuhara, K.
Kobayashi, T.
Nakao, M.
Takahashi, R.
Kaneko, H.
Shimura, K.
Hirakawa, K.
Uoshima, N.
Kamitsuji, Y.
Wada, K.
Kawata, E.
Isa, R.
Fujino, T.
Matsumura-Kimoto, Y.
Tsukamoto, T.
Mizutani, S.
Shimura, Y.
Taniwaki, M.
Kuroda, J.
P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title_full P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title_fullStr P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title_full_unstemmed P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title_short P1127: WATCHFUL WAITING IS AN ACCEPTABLE TREATMENT OPTION FOR PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA: A RETROSPECTIVE STUDY
title_sort p1127: watchful waiting is an acceptable treatment option for primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430938/
http://dx.doi.org/10.1097/01.HS9.0000847376.12611.2e
work_keys_str_mv AT mizuharak p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT kobayashit p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT nakaom p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT takahashir p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT kanekoh p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT shimurak p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT hirakawak p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT uoshiman p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT kamitsujiy p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT wadak p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT kawatae p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT isar p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT fujinot p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT matsumurakimotoy p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT tsukamotot p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT mizutanis p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT shimuray p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT taniwakim p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy
AT kurodaj p1127watchfulwaitingisanacceptabletreatmentoptionforprimaryocularadnexalmucosaassociatedlymphoidtissuelymphomaaretrospectivestudy